UCONN

HEALTH

Photo of Jessica M. Clement, M.D.

Jessica M. Clement, M.D.

Assistant Professor of Medicine
Academic Office Location:

UConn Health
263 Farmington Avenue
Farmington, CT 06030
Phone: 800-579-7822
860-679-2100
Website(s):

Neag Comprehensive Cancer Center

  • Looking for a Physician?

    This faculty member is also
    a practicing physician at UConn Health.

    Learn more >

Dr. Clement is an assistant professor of medicine in the Division of Hematology-Oncology and Neag Comprehensive Cancer Center. She specializes in the treatment of genitourinary (bladder, prostate, kidney, testicular) and gastrointestinal cancers.

Education
DegreeInstitutionMajor
B.S.Union CollegeBiology
M.D.Virginia Commonwealth UniversityMedicine

Post-Graduate Training
TrainingInstitutionSpecialty
InternshipBeth Israel Deaconess Medical CenterMedicine
ResidencyBeth Israel Deaconess Medical CenterMedicine
ResidencyBeth Israel Deaconess Medical CenterChief Resident, Internal Medicine
FellowshipBeth Israel Deaconess Medical CenterHematology-Oncology
Genitourinary malignancies (bladder, prostate, kidney and testicular cancers).
Name & DescriptionCategoryRoleTypeScopeStart YearEnd Year
Hematology-Oncology Utilization Review CommitteeProfessional/Scientific OrganizationReviewerExternalNational2015
Society of Urologic Oncology, Affiliate MemberProfessional/Scientific OrganizationMemberExternalNational2014
Albert Institute for Bladder Cancer Care and Research, Member of Scientific Advisory CommitteeProfessional/Scientific OrganizationMemberExternalNational20142015
Albert Institute for Bladder Cancer Care and ResearchProfessional/Scientific OrganizationBoard of DirectorsExternalNational2014
European UrologyProfessional/Scientific JournalReviewerExternalInternational2013
Journal of Translational MedicineProfessional/Scientific JournalReviewerExternalNational2012
University of Connecticut Health Center: Curriculum Policy SubcommitteeProfessional/Scientific OrganizationMemberUConn HealthUniversity2010
University of Connecticut Health Center: Chemotherapy Ordering System CommitteeProfessional/Scientific OrganizationMemberUConn HealthUniversity2010
University of Connecticut Health Center: Chemotherapy CommitteeProfessional/Scientific OrganizationMemberUConn HealthUniversity2010
University of Connecticut Health Center: Cancer Center Redesign CommitteeProfessional/Scientific OrganizationMemberUConn HealthUniversity20102011
Connecticut Medical SocietyProfessional/Scientific OrganizationMemberExternalState2010
Beth Israel Deaconess Medical Center: Ethics Advisory Committee LiaisonProfessional/Scientific OrganizationMemberExternalNational20062007
American Society of Clinical OncologyProfessional/Scientific OrganizationMemberExternalNational2006
Beth Israel Deaconess Medical Center: Healthcare Associates Narcotics Policy CommitteeProfessional/Scientific OrganizationMemberExternalLocal20052006
Beth Israel Deaconess Medical Center: Triggers Rapid Response Team Steering CommitteeProfessional/Scientific OrganizationMemberExternalState20052006
Beth Israel Deaconess Medical Center: Department of Medicine Intern Selection CommitteeProfessional/Scientific OrganizationMemberExternalState20052006
Beth Israel Deaconess Medical Center: Department of Medicine Housestaff Committee for Intern RecruitmentProfessional/Scientific OrganizationMemberExternalLocal20042005
Beth Israel Deaconess Medical Center: Department of Medicine Work Hours and Holiday Scheduling CommitteeProfessional/Scientific OrganizationMemberExternalLocal20032003
Massachusetts Medical SocietyProfessional/Scientific OrganizationMemberExternalNational2002
Dr. Clement is involved in bladder cancer research with Dr. John Taylor in the Division of Urologic Oncology.

Journal Articles

Abstracts

  • Carbonic Anhydrase IX (CA IX) and Pathologic Features as Predictors of Outcome in Patients with Metastatic Renal Cell Carcinoma (mRCC) Receiving VEGF-Targeted Therapy
    T.K. Choueiri, M.M. Regan, A.J. Brick, J.M. Clement, C. Kwabi, K. Shah, A. Amato, D.F. McDermott, M.B. Atkins, S. Signoretti Journal of Clinical Oncology: 2008 ASCO Annual Meeting Proceedings 26(15S):674s
  • Detecting Disparities in Long-Term Prostate Cancer (PCa) Survival with Dependent-Censoring
    Clement, J.M., Li, Y., Othus, M., Bubley, G. ASCO Genitourinary Cancers Symposium Abstract Number: 20
  • Patients with Metastatic Renal Cell Carcinoma (mRCC) Receiving Sunitinib in “Real-World” Clinical Practice: Baseline Characteristics and Treatment Efficacy
    J.M. Clement, D.F. McDermott, T.K. Choueiri, A.J. Brick, C. Kwabi, K. Shah, J.R. Weiner, M.S. Duh, M.P. Neary, W.K. Oh Supplement to Journal of Clinical Oncology: 2008 ASCO Annual Meeting Proceedings 26(15S):676s
  • Patients with Metastatic Renal Cell Carcinoma Receiving Angiogenesis Inhibitor Therapies: Treatment Efficacy and Safety in Clinical Practice
    McDermott, D., Choueiri, T.K., Clement, J., Brick, A.J., Kwabi, C., Shah, K., Banerjee, A., Duh, M.S., Neary, M., Oh, W.K. European Society for Medical Oncology Congress Abstract Number: 488
  • Treatment Discontinuations, Dose Reductions and Interruptions for Angiogenesis Inhibitor Therapies in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    A.J. Brick, D.F. McDermott, J.M. Clement, C. Kwabi, K. Shah, J.R. Weiner, M.S. Duh, M.P. Neary, W.K. Oh, T.K. Choueiri Supplement to Journal of Clinical Oncology: 2008 ASCO Annual Meeting Proceedings 26(15S):638s

Case Reports

Title or AbstractTypeSponsor/EventDate/YearLocation
ASCO Annual Meeting Poster Discussion Session Chair: Genitourinary (Non-prostate) Cancer TrackTalkASCO2016
Immune Checkpoint InhibitorsTalkASCO2016Oklahoma City, OK
The Evolving Management of Oligometastatic Prostate CancerTalkFox Chase Cancer Center2016Philadelphia, PA
Current Therapeutic Targets in Bladder CancerTalkAlbert Institute2015Minneapolis, MN
Addressing Patient and Physician Variables to Optimize Outcomes in Muscle Invasive Bladder CancerTalkAlbert Institute2014Hartford, CT
Advances in the Treatment of Castrate-Resistant Prostate Cancer, Urology Grand RoundsTalkUniversity of Connecticut Health Center/Hartford Hospital2013Connecticut
Bladder Cancer Update, Current Clinical MedicineTalkUniversity of Connecticut Health Center2013Farmington, Connecticut
Bladder Cancer Overview, Hematology-Oncology FellowsTalkUniversity of Connecticut Health Center2013Farmington, Connecticut
Association Between Pioglitazone (PZD) Therapy and Bladder Cancer (BC): A Meta-Analysis of Epidemiologic EvidencePosterASCO Annual Meeting2013
A Case of Small Cell Neuroendocrine Carcinoma in a Patient with Long-Standing Ulcerative ColitisPosterAmerican College of Gastroenterology Meeting2013
Myelodysplastic Syndromes, Internal Medicine Residency ProgramTalkUniversity of Connecticut Health Center2012Farmington, Connecticut
Soft Tissue Sarcomas, Medical Grand RoundsTalkUniversity of Connecticut Health Center2012Farmington, Connecticut
Renal Cell Carcinoma, Internal Medicine Residency ProgramTalkUniversity of Connecticut Health Center2012Farmington, Connecticut
Advances in the Treatment of Metastatic Prostate Cancer, Recent Advances in Internal MedicineTalkUniversity of Connecticut Health Center2011Farmington, Connecticut
Chemotherapy in Bladder Cancer, Urology Grand RoundsTalkUniversity of Connecticut Health Center2011Farmington, Connecticut
Renal Cell Carcinoma, Internal Medicine Residency ProgramTalkUniversity of Connecticut Health Center2011Farmington, Connecticut
Cancer Screening in the African-American PopulationTalkFaith Congregational Church2011Hartford, Connecticut
Clinical Application of Bone-Modulating Agents in Metastatic Castrate-Resistant Prostate CancerTalkCT Urology Society Annual Meeting2011Plantsville, Connecticut
Bladder Cancer, Collaborative Cancer ForumTalkUniversity of Connecticut Health Center2011Farmington, Connecticut
High-Dose Aldesleukin (IL-2) in Renal Cell Carcinoma: The Select TrialTalkUniversity of Connecticut Health Center2010Farmington, Connecticut
Detecting Disparities in Long-Term Prostate Cancer Survival with Dependent CensoringPosterASCO Genitourinary Cancers Symposium2009Orlando, Florida
Detecting Disparities in Long-Term Prostate Cancer Survival with Dependent CensoringTalkBeth Israel Deaconess Medical Center Hematology-Oncology Retreat2009Dedham, Massachusetts
Changing Survival in Prostate CancerTalkWake Forest Baptist Hospital2009Winston-Salem, North Carolina
Overview of Essential ThrombocythemiaTalkBeth Israel Deaconess Medical Center2007Boston, Massachusetts
Dose Dense Chemotherapy for Breast CancerTalkBeth Israel Deaconess Medical Center2007Boston, Massachusetts
Prognosis after Conservative Management in Triple-Negative Breast CancerTalkBeth Israel Deaconess Medical Center2007Boston, Massachusetts
Novel Agents in Chronic Lymphocytic LeukemiaTalkBeth Israel Deaconess Medical Center2007Boston, Massachusetts
Scleroderma Renal Crisis: A Case PresentationTalkBeth Israel Deaconess Medical Center2007Boston, Massachusetts
Salvage Chemotherapy in Small Cell Lung CancerTalkBeth Israel Deaconess Medical Center2007Boston, Massachusetts
Heinz-Body Hemolytic AnemiaTalkBeth Israel Deaconess Medical Center2007Boston, Massachusetts
Risk-Adapted Therapy for Hodgkins LymphomaTalkBeth Israel Deaconess Medical Center2007Boston, Massachusetts
Role of Debulking Nephrectomy in Metastatic Renal Cell CarcinomaTalkBeth Israel Deaconess Medical Center2006Boston, Massachusetts
Paraneoplastic Syndromes in Small Cell Lung CancerTalkBeth Israel Deaconess Medical Center2006Boston, Massachusetts
Androgen Deprivation Therapy and Radiation Therapy for Localized Prostate CancerTalkBeth Israel Deaconess Medical Center2006Boston, Massachusetts